학술논문
The safety and efficacy of first-line atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter real-world study from Turkey
Document Type
Article
Author
Akyildiz, A.; Guven, D.C.; Dizdar, O.; Yalcin, S.; Ozluk, A.A.; Goker, E.; Ismayilov, R.; Mutlu, E.; Unal, O.U.; Yildiz, I.; Iriagac, Y.; Turhal, S.; Akbas, S.; Bayram, E.; Telli, T.A.; Turkoz, F.P.; Ozcelik, M.; Erciyestepe, M.; Selvi, O.; Hacibekiroglu, İ.; Gulbagci, B.; Erturk, I.; Isleyen, Z.S.; Kahraman, S.; Sendur, M.A.; Akdag, M.O.; Hamitoglu, B.; Unek, I.T.; Unal, C.; Arslan, C.; Azizy, A.; Basaran, M.; Helvaci, K.; Demirci, U.
Source
In: Medicine (United States) . (Medicine (United States), 10 November 2023, 102(45):E35950)
Subject
Language
English
ISSN
15365964
00257974
00257974